Aeterna Zentaris
AEZS
#10591
Rank
A$25.02 M
Marketcap
A$8.17
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$2.93. In 2022 the company made an earnings per share (EPS) of A-$6.69 a decrease over its 2021 EPS that were of A-$2.60.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.69157.14%
2021A-$2.60-41.48%
2020A-$4.44-64.46%
2019A-$12.50-240%
2018A$8.93-122.32%
2017A-$40.01-53.53%
2016A-$86.10-86.71%
2015A-$648.10-35.21%
2014A-$1,000-216.67%
2013A$857.46-123.3%
2012A-$3,680-40.8%
2011A-$6,217-6.45%
2010A-$6,645-27.91%
2009A-$9,218-61.61%
2008A-$24,00983.61%
2007A-$13,076-195.31%
2006A$13,719178.26%
2005A$4,930-330%
2004A-$2,144-80.05%
2003A-$10,74517.78%
2002A-$9,123515.93%
2001A-$1,481-68.6%
2000A-$4,718119.62%
1999A-$2,148-3.63%
1998A-$2,229

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$10.03-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$3.66-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$5.09-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$4.17-242.51%๐Ÿ‡บ๐Ÿ‡ธ USA